Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Pharma Data
Emerging Trends and Risks in Clinical Data Management
Looking to the next few years of data management in clinical trials, hybrid models which interpolate AI and ML approaches to assist trial coordinators will increasingly become the new normal.
Pharma Data
Leveraging Compound and Therapeutic Antibody Analytical Data
Analytical data is a key tool which can be leveraged to augment digital drug discovery if data workflows are properly implemented.
Positive Results Achieved from Phase III Trial of MDMA-Assisted Therapy
Significant findings after the Schedule I controlled drug completes Phase III clinical trial for PTSD patients.
Molecular Drug Design
FDA Release New Guidance for Modifications to AI/ML-Enabled Devices
The FDA has proposed new guidance which favours a science-based approach for AI/ML-Enabled devices to be modified and improved more quickly.
Discovery of Fentanyl Vaccine Called “Game Changer” with Some Sceptical
The antibody-based vaccine has been successful in rat models but has had critics who would rather see a focus on harm reduction.
Target Discovery
Addressing Specific Targets and Dealing with Target Engagement
The panel discussion from Discovery US 2022, investigates into new technologies for target engagement and expanding the chemical space.
Pharma Data
FAIR Data Principles and Use Cases in Pharma
FAIR data principles aim to standardise and enhance the management of scientific data through unique identifiers and standardised protocols. The gradual implementation of these principles can improve research efficiency, facilitating better data utilisation by both humans and machines.
Pharma Data
In Conversation With Dr. Maya Natarajan, Neo4J
In the lead up to our 2022 Pharma Data & SmartLabs Congress taking place this September, we sat down with Maya Natarajan, Senior Director Knowledge Graphs at Neo4j. Being a key player within the field, Maya gave us insights into the pioneering work Neo4j is doing with knowledge graphs and the types of graph analytics that Neo4J provides.
Target Discovery
University of Minnesota Awarded $6.5m for Male Contraceptive Discovery Effort
The grant could open the door to new oral contraceptive medication for men and prevent unwanted pregnancy.
Automation
Pharmaceutical Automation and the Factories of the Future: How Will the Industry Look in 2030?
With every new technological innovation, the pharmaceutical industry moves closer to the broader introduction of automation in production lines. But what bumps in the road to progress need to be smoothed out when it comes to the standardisation of industry approaches?
Discussion Group Report - Mobile Robotics
This November, our PharmaTec Series discussion group focused on mobile robotics. We explored their current uses, challenges and potential.
Target Discovery
Accelerating Target Discovery with Genomic and CRISPR Techniques
Benedict Cross, Chief Technology Officer at PhoreMost, leads our Discussion Group on Target-Based Drug Discovery using Genomic and CRISPR techniques.